share_log

W.P. Carey Analyst Ratings

Benzinga ·  Sep 22, 2023 11:12
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/22/2023 14.64% Evercore ISI Group $76 → $66 Maintains In-Line
08/30/2023 19.85% Citigroup $75 → $69 Maintains Neutral
08/14/2023 16.38% B of A Securities $78 → $67 Downgrades Neutral → Underperform
07/31/2023 37.22% RBC Capital $81 → $79 Maintains Outperform
06/23/2023 38.96% JMP Securities $86 → $80 Maintains Market Outperform
06/14/2023 28.54% Exane BNP Paribas → $74 Initiates Coverage On → Underperform
06/14/2023 35.49% Raymond James $85 → $78 Maintains Outperform
05/01/2023 40.7% RBC Capital $80 → $81 Maintains Outperform
04/26/2023 49.38% JMP Securities → $86 Reiterates → Market Outperform
03/21/2023 49.38% JMP Securities → $86 Reiterates → Market Outperform
02/13/2023 52.86% RBC Capital $86 → $88 Maintains Outperform
12/19/2022 47.65% Raymond James $80 → $85 Maintains Outperform
10/24/2022 49.38% JMP Securities $93 → $86 Maintains Market Outperform
10/04/2022 38.96% Raymond James $95 → $80 Maintains Outperform
08/03/2022 61.54% JMP Securities $87 → $93 Maintains Market Outperform
08/01/2022 63.28% RBC Capital $87 → $94 Maintains Outperform
07/08/2022 65.02% Raymond James $90 → $95 Maintains Outperform
06/28/2022 52.86% Wolfe Research → $88 Initiates Coverage On → Peer Perform
06/23/2022 Evercore ISI Group Downgrades Outperform → In-Line
05/10/2022 51.12% JMP Securities → $87 Initiates Coverage On → Market Outperform
04/14/2022 56.33% Raymond James → $90 Initiates Coverage On → Outperform
01/20/2022 B of A Securities Upgrades Underperform → Neutral
11/01/2021 51.12% RBC Capital $89 → $87 Maintains Outperform
09/17/2021 54.59% RBC Capital → $89 Initiates Coverage On → Outperform
06/23/2021 56.33% Wells Fargo $77 → $90 Maintains Overweight
06/15/2021 52.86% JP Morgan $77 → $88 Upgrades Neutral → Overweight
04/07/2021 B of A Securities Downgrades Buy → Underperform
06/10/2020 33.75% Wells Fargo $64 → $77 Maintains Overweight
04/07/2020 -9.68% Citigroup $83 → $52 Maintains Neutral
04/02/2020 11.17% Wells Fargo $92 → $64 Maintains Overweight
03/02/2020 44.17% Citigroup $81 → $83 Maintains Neutral
12/10/2019 59.81% Wells Fargo → $92 Upgrades Market Perform → Outperform
11/11/2019 52.86% Evercore ISI Group → $88 Upgrades Underperform → In-Line
10/25/2019 75.44% BMO Capital → $101 Initiates Coverage On → Outperform
06/07/2019 40.7% Citigroup $59 → $81 Upgrades Sell → Neutral
03/26/2019 35.49% Mitsubishi UFJ → $78 Initiates Coverage On → Neutral
12/19/2018 26.8% JP Morgan → $73 Initiates Coverage On → Neutral

What is the target price for W.P. Carey (WPC)?

The latest price target for W.P. Carey (NYSE: WPC) was reported by Evercore ISI Group on September 22, 2023. The analyst firm set a price target for $66.00 expecting WPC to rise to within 12 months (a possible 14.64% upside). 14 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for W.P. Carey (WPC)?

The latest analyst rating for W.P. Carey (NYSE: WPC) was provided by Evercore ISI Group, and W.P. Carey maintained their in-line rating.

When is the next analyst rating going to be posted or updated for W.P. Carey (WPC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of W.P. Carey, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for W.P. Carey was filed on September 22, 2023 so you should expect the next rating to be made available sometime around September 22, 2024.

Is the Analyst Rating W.P. Carey (WPC) correct?

While ratings are subjective and will change, the latest W.P. Carey (WPC) rating was a maintained with a price target of $76.00 to $66.00. The current price W.P. Carey (WPC) is trading at is $57.57, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment